<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-04322943</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-23T07:02:31+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Avelumab vs Standard Second-Line Chemotherapy in Patients with Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial</title>
            <author role="aut">
              <persName>
                <forename type="first">Julien</forename>
                <surname>Taïeb</surname>
              </persName>
              <idno type="halauthorid">464951-0</idno>
              <affiliation ref="#struct-300119"/>
              <affiliation ref="#struct-1004777"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Olivier</forename>
                <surname>Bouche</surname>
              </persName>
              <idno type="halauthorid">465892-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Thierry</forename>
                <surname>André</surname>
              </persName>
              <idno type="halauthorid">388124-0</idno>
              <affiliation ref="#struct-1081317"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Karine</forename>
                <surname>Le Malicot</surname>
              </persName>
              <idno type="halauthorid">719475-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Pierre</forename>
                <surname>Laurent-Puig</surname>
              </persName>
              <email type="md5">90bda4a5a3d53680d817d4c5e51c23b4</email>
              <email type="domain">univ-paris5.fr</email>
              <idno type="idhal" notation="numeric">757353</idno>
              <idno type="halauthorid" notation="string">179070-757353</idno>
              <idno type="ORCID">https://orcid.org/0000-0001-8475-5459</idno>
              <idno type="IDREF">https://www.idref.fr/071013512</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Jérémie</forename>
                <surname>Bez</surname>
              </persName>
              <idno type="halauthorid">1477235-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Clémence</forename>
                <surname>Toullec</surname>
              </persName>
              <idno type="halauthorid">2218428-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Christophe</forename>
                <surname>Borg</surname>
              </persName>
              <idno type="halauthorid">161963-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Violaine</forename>
                <surname>Randrian</surname>
              </persName>
              <idno type="halauthorid">1579276-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Ludovic</forename>
                <surname>Evesque</surname>
              </persName>
              <idno type="halauthorid">1710316-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Stéphane</forename>
                <surname>Corbinais</surname>
              </persName>
              <idno type="halauthorid">2376662-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Hervé</forename>
                <surname>Perrier</surname>
              </persName>
              <idno type="halauthorid">1214431-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Bruno</forename>
                <surname>Buecher</surname>
              </persName>
              <idno type="halauthorid">414727-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Frederic</forename>
                <surname>Di Fiore</surname>
              </persName>
              <idno type="halauthorid">889474-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Claire</forename>
                <surname>Gallois</surname>
              </persName>
              <idno type="halauthorid">1387987-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Jean Francois</forename>
                <surname>Emile</surname>
              </persName>
              <idno type="halauthorid">638495-0</idno>
              <affiliation ref="#struct-526041"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Côme</forename>
                <surname>Lepage</surname>
              </persName>
              <idno type="halauthorid">360467-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Farid</forename>
                <surname>Elhajbi</surname>
              </persName>
              <idno type="halauthorid">1307333-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">David</forename>
                <surname>Tougeron</surname>
              </persName>
              <email type="md5">22f7dd3ac2329de0f7950b1468fb7efc</email>
              <email type="domain">chu-poitiers.fr</email>
              <idno type="idhal" notation="numeric">762473</idno>
              <idno type="halauthorid" notation="string">451943-762473</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-8065-9635</idno>
              <idno type="IDREF">https://www.idref.fr/110742478</idno>
              <idno type="VIAF">https://viaf.org/viaf/220251499</idno>
              <idno type="ISNI">http://isni.org/isni/0000000359511772</idno>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Équipe</forename>
                <surname>HAL UVSQ</surname>
              </persName>
              <email type="md5">5808107ddbade13399d417929c0cb718</email>
              <email type="domain">uvsq.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2023-12-05 13:06:07</date>
              <date type="whenModified">2025-10-29 03:18:28</date>
              <date type="whenReleased">2023-12-06 07:58:53</date>
              <date type="whenProduced">2023-10-19</date>
              <date type="whenEndEmbargoed">2024-06-05</date>
              <ref type="file" target="https://hal.science/hal-04322943v1/document">
                <date notBefore="2024-06-05"/>
              </ref>
              <ref type="file" subtype="author" n="1" target="https://hal.science/hal-04322943v1/file/jamaoncology_taeb_2023_oi_230035_1697125901.57612.pdf" id="file-4323531-3768701">
                <date notBefore="2024-06-05"/>
              </ref>
              <ref type="externalLink" target="https://jamanetwork.com/journals/jamaoncology/articlepdf/2808072/jamaoncology_taeb_2023_oi_230035_1691003400.49699.pdf"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="751146">
                <persName>
                  <forename>Équipe</forename>
                  <surname>HAL UVSQ</surname>
                </persName>
                <email type="md5">5808107ddbade13399d417929c0cb718</email>
                <email type="domain">uvsq.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-04322943</idno>
            <idno type="halUri">https://hal.science/hal-04322943</idno>
            <idno type="halBibtex">taieb:hal-04322943</idno>
            <idno type="halRefHtml">&lt;i&gt;JAMA oncology&lt;/i&gt;, 2023, 9 (10), &lt;a target="_blank" href="https://dx.doi.org/10.1001/jamaoncol.2023.2761"&gt;&amp;#x27E8;10.1001/jamaoncol.2023.2761&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">JAMA oncology, 2023, 9 (10), &amp;#x27E8;10.1001/jamaoncol.2023.2761&amp;#x27E9;</idno>
            <availability status="restricted">
              <licence target="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 - Attribution<ref corresp="#file-4323531-3768701"/></licence>
            </availability>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="EPHE">École Pratique des Hautes Études</idno>
            <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
            <idno type="stamp" n="APHP" corresp="INSERM">AP-HP</idno>
            <idno type="stamp" n="LORIA2">Publications du LORIA</idno>
            <idno type="stamp" n="CORDELIERS" corresp="SORBONNE-UNIVERSITE">Centre de recherche des Cordeliers</idno>
            <idno type="stamp" n="UVSQ">Université de Versailles Saint-Quentin-en-Yvelines</idno>
            <idno type="stamp" n="PSL">Université Paris sciences et lettres</idno>
            <idno type="stamp" n="UNIV-PARIS-SACLAY">Université Paris-Saclay</idno>
            <idno type="stamp" n="CHU-UNIV-PARIS5">Les centres hospitaliers de Paris Descartes</idno>
            <idno type="stamp" n="SORBONNE-UNIVERSITE">Sorbonne Université</idno>
            <idno type="stamp" n="SORBONNE-UNIV" corresp="SORBONNE-UNIVERSITE">Sorbonne Université 01/01/2018</idno>
            <idno type="stamp" n="BCOH">Biomarqueurs et Essais Cliniques en Cancérologie et Onco-Hématologie</idno>
            <idno type="stamp" n="SU-SCIENCES" corresp="SORBONNE-UNIVERSITE">Faculté des Sciences de Sorbonne Université</idno>
            <idno type="stamp" n="TEST-DEV">TEST-DEV</idno>
            <idno type="stamp" n="UNIV-PARIS">Université Paris Cité</idno>
            <idno type="stamp" n="UNIVERSITE-PARIS" corresp="UNIV-PARIS">Université Paris Cité</idno>
            <idno type="stamp" n="UP-SANTE">Université Paris Cité - Faculté de Santé</idno>
            <idno type="stamp" n="EPHE-PSL" corresp="PSL">École Pratique des Hautes Études - PSL</idno>
            <idno type="stamp" n="UVSQ-UPSACLAY" corresp="UNIV-PARIS-SACLAY">UVSQ-UPSACLAY</idno>
            <idno type="stamp" n="UNIVERSITE-PARIS-SACLAY" corresp="UNIV-PARIS-SACLAY">Université Paris-Saclay</idno>
            <idno type="stamp" n="SU-TI">Sorbonne Université - Texte Intégral</idno>
            <idno type="stamp" n="GS-LIFE-SCIENCES-HEALTH" corresp="UNIVERSITE-PARIS-SACLAY">Graduate School Life Sciences and Health</idno>
            <idno type="stamp" n="ALLIANCE-SU"> Alliance Sorbonne Université</idno>
            <idno type="stamp" n="PRODICET">Laboratoire PROgression et DIssémination CErébrales des cellules Tumorales</idno>
            <idno type="stamp" n="SUPRA_BIOLOGIE">Biologie hors MNHN &amp; stations</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Avelumab vs Standard Second-Line Chemotherapy in Patients with Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Julien</forename>
                    <surname>Taïeb</surname>
                  </persName>
                  <idno type="halauthorid">464951-0</idno>
                  <affiliation ref="#struct-300119"/>
                  <affiliation ref="#struct-1004777"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Olivier</forename>
                    <surname>Bouche</surname>
                  </persName>
                  <idno type="halauthorid">465892-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Thierry</forename>
                    <surname>André</surname>
                  </persName>
                  <idno type="halauthorid">388124-0</idno>
                  <affiliation ref="#struct-1081317"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Karine</forename>
                    <surname>Le Malicot</surname>
                  </persName>
                  <idno type="halauthorid">719475-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Pierre</forename>
                    <surname>Laurent-Puig</surname>
                  </persName>
                  <email type="md5">90bda4a5a3d53680d817d4c5e51c23b4</email>
                  <email type="domain">univ-paris5.fr</email>
                  <idno type="idhal" notation="numeric">757353</idno>
                  <idno type="halauthorid" notation="string">179070-757353</idno>
                  <idno type="ORCID">https://orcid.org/0000-0001-8475-5459</idno>
                  <idno type="IDREF">https://www.idref.fr/071013512</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Jérémie</forename>
                    <surname>Bez</surname>
                  </persName>
                  <idno type="halauthorid">1477235-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Clémence</forename>
                    <surname>Toullec</surname>
                  </persName>
                  <idno type="halauthorid">2218428-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Christophe</forename>
                    <surname>Borg</surname>
                  </persName>
                  <idno type="halauthorid">161963-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Violaine</forename>
                    <surname>Randrian</surname>
                  </persName>
                  <idno type="halauthorid">1579276-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Ludovic</forename>
                    <surname>Evesque</surname>
                  </persName>
                  <idno type="halauthorid">1710316-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Stéphane</forename>
                    <surname>Corbinais</surname>
                  </persName>
                  <idno type="halauthorid">2376662-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Hervé</forename>
                    <surname>Perrier</surname>
                  </persName>
                  <idno type="halauthorid">1214431-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Bruno</forename>
                    <surname>Buecher</surname>
                  </persName>
                  <idno type="halauthorid">414727-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Frederic</forename>
                    <surname>Di Fiore</surname>
                  </persName>
                  <idno type="halauthorid">889474-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Claire</forename>
                    <surname>Gallois</surname>
                  </persName>
                  <idno type="halauthorid">1387987-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Jean Francois</forename>
                    <surname>Emile</surname>
                  </persName>
                  <idno type="halauthorid">638495-0</idno>
                  <affiliation ref="#struct-526041"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Côme</forename>
                    <surname>Lepage</surname>
                  </persName>
                  <idno type="halauthorid">360467-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Farid</forename>
                    <surname>Elhajbi</surname>
                  </persName>
                  <idno type="halauthorid">1307333-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">David</forename>
                    <surname>Tougeron</surname>
                  </persName>
                  <email type="md5">22f7dd3ac2329de0f7950b1468fb7efc</email>
                  <email type="domain">chu-poitiers.fr</email>
                  <idno type="idhal" notation="numeric">762473</idno>
                  <idno type="halauthorid" notation="string">451943-762473</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-8065-9635</idno>
                  <idno type="IDREF">https://www.idref.fr/110742478</idno>
                  <idno type="VIAF">https://viaf.org/viaf/220251499</idno>
                  <idno type="ISNI">http://isni.org/isni/0000000359511772</idno>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">113058</idno>
                <idno type="issn">2374-2437</idno>
                <title level="j">JAMA oncology</title>
                <imprint>
                  <publisher>American Medical Association</publisher>
                  <biblScope unit="volume">9</biblScope>
                  <biblScope unit="issue">10</biblScope>
                  <date type="datePub">2023-10-19</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1001/jamaoncol.2023.2761</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <classCode scheme="halDomain" n="sdv">Life Sciences [q-bio]</classCode>
              <classCode scheme="halDomain" n="sdv.bbm">Life Sciences [q-bio]/Biochemistry, Molecular Biology</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Importance: Only 1 randomized clinical trial has shown the superiority of immune checkpoint inhibitors in patients with deficient mismatch repair and/or microsatellite instability (dMMR/MSI) metastatic colorectal cancer (mCRC) in the first-line setting. Objectives: To determine whether avelumab (an anti-programmed cell death ligand 1 antibody) improves progression-free survival (PFS) compared with standard second-line chemotherapy in patients with dMMR/MSI mCRC. Design, Setting, and Participants: The SAMCO-PRODIGE 54 trial is a national open-label phase 2 randomized clinical trial that was conducted from April 24, 2018, to April 29, 2021, at 49 French sites. Patients with dMMR/MSI mCRC who experienced progression while receiving standard first-line therapy were included in the analysis. Interventions: Patients were randomized to receive standard second-line therapy or avelumab every 2 weeks until progression, unacceptable toxic effects, or patient refusal. Main Outcome and Measures: The primary end point was PFS according to RECIST (Response Evaluation Criteria in Solid Tumours), version 1.1, evaluated by investigators in patients with mCRC and confirmed dMMR and MSI status who received at least 1 dose of treatment (modified intention-to-treat [mITT] population). Results: A total of 122 patients were enrolled in the mITT population. Median age was 66 (IQR, 56-76) years, 65 patients (53.3%) were women, 100 (82.0%) had a right-sided tumor, and 52 (42.6%) had BRAF V600E-mutated tumors. There was no difference in patients and tumor characteristics between treatment groups. No new safety concerns in either group were detected, with fewer treatment-related adverse events of at least grade 3 in the avelumab group than in the chemotherapy group (20 [31.7%] vs 34 [53.1%]; P =.02). After a median follow-up of 33.3 (95% CI, 28.3-34.8) months, avelumab was superior to chemotherapy with or without targeted agents with respect to PFS (15 [24.6%] vs 5 [8.2%] among patients without progression; P =.03). Rates of PFS rates at 12 months were 31.2% (95% CI, 20.1%-42.9%) and 19.4% (95% CI, 10.6%-30.2%) in the avelumab and control groups, respectively, and 27.4% (95% CI, 16.8%-39.0%) and 9.1% (95% CI, 3.2%-18.8%) at 18 months. Objective response rates were similar in both groups (18 [29.5%] vs 16 [26.2%]; P =.45). Among patients with disease control, 18 (75.7%) in the avelumab group compared with 9 (19.1%) in the control group had ongoing disease control at 18 months. Conclusions: The SAMCO-PRODIGE 54 phase 2 randomized clinical trial showed, in patients with dMMR/MSI mCRC, better PFS and disease control duration with avelumab over standard second-line treatment, with a favorable safety profile. Trial Registration: ClinicalTrials.gov Identifier: NCT03186326.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="institution" xml:id="struct-300119" status="VALID">
          <idno type="IdRef">052497380</idno>
          <idno type="ROR">https://ror.org/016vx5156</idno>
          <orgName>Hôpital Européen Georges Pompidou [APHP]</orgName>
          <orgName type="acronym">HEGP</orgName>
          <desc>
            <address>
              <addrLine>20, rue Leblanc, 75015 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://hopital-georgespompidou.aphp.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-300068" type="direct"/>
            <relation active="#struct-353414" type="direct"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-1004777" status="VALID">
          <idno type="IdRef">158039203</idno>
          <idno type="ISNI">0000 0004 0620 5824 </idno>
          <idno type="RNSR">200716512X</idno>
          <orgName>Centre de Recherche des Cordeliers</orgName>
          <orgName type="acronym">CRC (UMR_S_1138 / U1138)</orgName>
          <date type="start">2020-01-01</date>
          <desc>
            <address>
              <addrLine>15 rue de l'Ecole de Médecine - Bâtiment B - 75270 Paris Cedex 06</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.crc.jussieu.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-110691" type="direct"/>
            <relation active="#struct-564132" type="indirect"/>
            <relation name="U1138" active="#struct-303623" type="direct"/>
            <relation active="#struct-413221" type="direct"/>
            <relation name="UMR_S_1138" active="#struct-557826" type="direct"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-1081317" status="VALID">
          <orgName>Site de recherche intégrée en cancérologie</orgName>
          <orgName type="acronym">SiRIC CURAMUS</orgName>
          <desc>
            <address>
              <addrLine>Site Pitié Salpêtrière83 boulevard de l’hôpital 75013 PARIS</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://curamus-cancer.fr/presentation-du-siric-curamus/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-581174" type="direct"/>
            <relation active="#struct-300068" type="indirect"/>
            <relation active="#struct-303623" type="indirect"/>
            <relation active="#struct-413221" type="indirect"/>
            <relation active="#struct-441569" type="indirect"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-526041" status="VALID">
          <idno type="IdRef">197624227</idno>
          <idno type="RNSR">200815569T</idno>
          <idno type="ROR">https://ror.org/05r0mw364</idno>
          <orgName>Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie</orgName>
          <orgName type="acronym">BECCOH</orgName>
          <date type="start">2008-01-01</date>
          <desc>
            <address>
              <addrLine>Hôpital Ambroise Paré, 9 avenue Charles de Gaulle92104 Boulogne</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.uvsq.fr/biomarqueurs-en-cancerologie-et-onco-hematologie-bcoh--38702.kjsp</ref>
          </desc>
          <listRelation>
            <relation name="UR 4340" active="#struct-81173" type="direct"/>
            <relation active="#struct-419361" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-300068" status="VALID">
          <idno type="ROR">https://ror.org/00pg5jh14</idno>
          <orgName>Assistance publique - Hôpitaux de Paris (AP-HP)</orgName>
          <orgName type="acronym">AP-HP</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-353414" status="VALID">
          <orgName>Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest</orgName>
          <orgName type="acronym">HUPO</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">http://hopitaux-parisouest.aphp.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-110691" status="VALID">
          <idno type="IdRef">026375478</idno>
          <idno type="ISNI">0000000121955365</idno>
          <idno type="ROR">https://ror.org/046b3cj80</idno>
          <orgName>École Pratique des Hautes Études</orgName>
          <orgName type="acronym">EPHE</orgName>
          <date type="start">1868-01-01</date>
          <desc>
            <address>
              <addrLine>4-14 Rue Ferrus, 75014 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.ephe.fr</ref>
          </desc>
          <listRelation>
            <relation active="#struct-564132" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-564132" status="VALID">
          <idno type="IdRef">241597595</idno>
          <idno type="ISNI">0000 0004 1784 3645</idno>
          <idno type="ROR">https://ror.org/013cjyk83</idno>
          <orgName>Université Paris Sciences et Lettres</orgName>
          <orgName type="acronym">PSL</orgName>
          <desc>
            <address>
              <addrLine>60 rue Mazarine 75006 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.psl.eu/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-413221" status="VALID">
          <idno type="IdRef">221333754</idno>
          <idno type="ROR">https://ror.org/02en5vm52</idno>
          <orgName>Sorbonne Université</orgName>
          <orgName type="acronym">SU</orgName>
          <date type="start">2018-01-01</date>
          <desc>
            <address>
              <addrLine>21 rue de l’École de médecine - 75006 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.sorbonne-universite.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-557826" status="VALID">
          <idno type="IdRef">236453505</idno>
          <idno type="ISNI">0000 0004 7885 7602</idno>
          <idno type="ROR">https://ror.org/05f82e368</idno>
          <orgName>Université Paris Cité</orgName>
          <orgName type="acronym">UPCité</orgName>
          <date type="start">2020-01-01</date>
          <desc>
            <address>
              <addrLine>85 boulevard Saint-Germain75006 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://u-paris.fr/</ref>
          </desc>
        </org>
        <org type="regrouplaboratory" xml:id="struct-581174" status="VALID">
          <orgName>Institut Universitaire de Cancérologie [Sorbonne Université]</orgName>
          <orgName type="acronym">IUC</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://iuc-aphp-sorbonneuniversite.com/presentation-de-iuc/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-300068" type="direct"/>
            <relation active="#struct-303623" type="direct"/>
            <relation active="#struct-413221" type="direct"/>
            <relation active="#struct-441569" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-441569" status="VALID">
          <idno type="IdRef">02636817X</idno>
          <idno type="ISNI">0000000122597504</idno>
          <idno type="ROR">https://ror.org/02feahw73</idno>
          <orgName>Centre National de la Recherche Scientifique</orgName>
          <orgName type="acronym">CNRS</orgName>
          <date type="start">1939-10-19</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.cnrs.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-81173" status="VALID">
          <idno type="IdRef">03082057X</idno>
          <idno type="ISNI">0000 0001 2323 0229 </idno>
          <idno type="ROR">https://ror.org/03mkjjy25</idno>
          <orgName>Université de Versailles Saint-Quentin-en-Yvelines</orgName>
          <orgName type="acronym">UVSQ</orgName>
          <date type="start">1991-07-22</date>
          <desc>
            <address>
              <addrLine>55 avenue de Paris - 78035 Versailles cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.uvsq.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-419361" status="VALID">
          <idno type="IdRef">241345251</idno>
          <idno type="ROR">https://ror.org/03xjwb503</idno>
          <orgName>Université Paris-Saclay</orgName>
          <desc>
            <address>
              <addrLine>Bâtiment Bréguet, 3 Rue Joliot Curie 2e ét, 91190 Gif-sur-Yvette</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.universite-paris-saclay.fr/fr</ref>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>